1. Home
  2. COEP vs ORKT Comparison

COEP vs ORKT Comparison

Compare COEP & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ORKT
  • Stock Information
  • Founded
  • COEP 2017
  • ORKT 2003
  • Country
  • COEP United States
  • ORKT Singapore
  • Employees
  • COEP N/A
  • ORKT N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ORKT
  • Sector
  • COEP Health Care
  • ORKT
  • Exchange
  • COEP Nasdaq
  • ORKT NYSE
  • Market Cap
  • COEP 32.4M
  • ORKT 34.7M
  • IPO Year
  • COEP N/A
  • ORKT 2024
  • Fundamental
  • Price
  • COEP $11.54
  • ORKT $1.30
  • Analyst Decision
  • COEP
  • ORKT Strong Buy
  • Analyst Count
  • COEP 0
  • ORKT 1
  • Target Price
  • COEP N/A
  • ORKT $5.00
  • AVG Volume (30 Days)
  • COEP 136.7K
  • ORKT 8.2M
  • Earning Date
  • COEP 03-25-2025
  • ORKT 10-16-2024
  • Dividend Yield
  • COEP N/A
  • ORKT N/A
  • EPS Growth
  • COEP N/A
  • ORKT N/A
  • EPS
  • COEP N/A
  • ORKT N/A
  • Revenue
  • COEP N/A
  • ORKT $3,904,592.00
  • Revenue This Year
  • COEP N/A
  • ORKT N/A
  • Revenue Next Year
  • COEP N/A
  • ORKT N/A
  • P/E Ratio
  • COEP N/A
  • ORKT N/A
  • Revenue Growth
  • COEP N/A
  • ORKT N/A
  • 52 Week Low
  • COEP $2.31
  • ORKT $0.62
  • 52 Week High
  • COEP $13.70
  • ORKT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • ORKT N/A
  • Support Level
  • COEP $8.65
  • ORKT N/A
  • Resistance Level
  • COEP $13.70
  • ORKT N/A
  • Average True Range (ATR)
  • COEP 2.11
  • ORKT 0.00
  • MACD
  • COEP -0.24
  • ORKT 0.00
  • Stochastic Oscillator
  • COEP 61.22
  • ORKT 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

Share on Social Networks: